TIMPs, MMPs and cardiovascular disease

European Heart Journal

Volumn 25, Issue 17, 2004, Pages 1475-1476

  Messerli, Franz H ^a  

^a OCHSNER CLINIC FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIASTOLE; EDITORIAL; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE FIBROSIS; HEART VENTRICLE REMODELING; HUMAN; ISCHEMIC HEART DISEASE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RISK ASSESSMENT; SCORING SYSTEM;

CARDIOVASCULAR DISEASES; HUMANS; MATRIX METALLOPROTEINASE 9; RISK FACTORS; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 4444284276     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ehj.2004.07.015     Document Type: Editorial

References (6)

1. C.M. Dollery, J.R. McEwan, and A.M. Henney Matrix metalloproteinases and cardiovascular disease Circ. Res. 77 1995 863 868
2. M.M. Lindsay, P. Maxwell, and F.G. Dunn TIMP-1: a marker of left ventricular diastolic dysfunction and fibrosis in hypertension Hypertension 40 2002 136 141
3. F.H. Messerli, and B.S. Mittler Framingham at 50 Lancet 352 1998 1006 [Commentary]
4. J. Sundström, J.C. Evans, and E.J. Benjamin Relations of plasma total tissue inhibitor of metalloproteinases-1 levels to cardiovascular risk factors and echocardiographic measures: the Framingham Heart Study Eur. Heart J. 25 2004 1509 1516
5. J. Sundstrom, J.C. Evans, and E.J. Benjamin Relations of plasma matrix metalloproteinase-9 to clinical cardiovascular risk factors and echocardiographic left ventricular measures Circulation 109 2004 2850 2856
6. B. Folkow "Structural factor" in primary and secondary hypertension Hypertension 16 1990 89 101